Warning: The NCBI web site requires JavaScript to function. more...
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N.
Arthritis Res Ther. 2006;8(5):R152.
Related citations
Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.
Arthritis Rheum. 2004 May;50(5):1457-67.
Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD, Zhao B, Triantafyllopoulou A, Park-Min KH, Ivashkiv LB.
Arthritis Rheum. 2010 Feb;62(2):402-13.
Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR, Wang JH, Hsieh SL, Wang SM, Hsu TL, Lin WW.
Cell Death Differ. 2004 Jul;11 Suppl 1:S97-107.
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T, Danks L, Sabokbar A, Athanasou NA.
Rheumatology (Oxford). 2002 Nov;41(11):1232-9.
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM, Nishioka K, Yudoh K.
Ann Rheum Dis. 2004 Nov;63(11):1379-86.
T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis.
Kotake S, Nanke Y, Kawamoto M, Yago T, Udagawa N, Ichikawa N, Kobashigawa T, Saito S, Momohara S, Kamatani N, Yamanaka H.
Bone. 2009 Oct;45(4):627-39. Epub 2009 Jun 25.
NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K.
Arthritis Res Ther. 2007;9(5):R97.
Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H, Sugiyama E, Mohamed SG, Shinoda K, Taki H, Abdel-Aziz HO, Maruyama M, Kobayashi M, Miyahara T.
Bone. 2008 Apr;42(4):765-74. Epub 2007 Dec 15.
Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production.
Tsuboi H, Udagawa N, Hashimoto J, Yoshikawa H, Takahashi N, Ochi T.
Arthritis Rheum. 2005 Dec;52(12):3819-28.
Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K, Yamamura M, Iwahashi M, Otsuka F, Yamana J, Sunahori K, Kawashima M, Yamada M, Makino H.
Arthritis Res Ther. 2006;8(4):R126.
Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH, Ryu SY, Choi JS, Min YK, Kim SH.
J Cell Physiol. 2009 Dec;221(3):618-28.
[Molecular mechanisms of bone destruction in rheumatoid arthritis].
Nanki T.
Clin Calcium. 2007 Apr;17(4):510-6. Review. Japanese.
CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
Lee HY, Jeon HS, Song EK, Han MK, Park SI, Lee SI, Yun HJ, Kim JR, Kim JS, Lee YC, Kim SI, Kim HR, Choi JY, Kang I, Kim HY, Yoo WH.
Arthritis Rheum. 2006 Jun;54(6):1747-58.
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
Karsdal MA, Hjorth P, Henriksen K, Kirkegaard T, Nielsen KL, Lou H, Delaissé JM, Foged NT.
J Biol Chem. 2003 Nov 7;278(45):44975-87. Epub 2003 Aug 20.
Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
Kim YG, Lee CK, Oh JS, Kim SH, Kim KA, Yoo B.
Arthritis Rheum. 2010 Feb;62(2):515-23.
Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45.
Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P.
J Bone Miner Res. 2006 Feb;21(2):193-206. Epub 2005 Nov 7.
Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.
Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, Tanaka S, Kim HM, Kim HH, Lee ZH.
Blood. 2005 Apr 1;105(7):2963-9. Epub 2004 Dec 7.
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P.
Blood. 2004 Oct 1;104(7):2044-50. Epub 2004 Jun 22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on